Mengni Yi

The potassium channel KCa3.1 constitutes a pharmacological target for astrogliosis associated with ischemia stroke

H. M. Geller, Hongzhuan Chen, Yanxia Wang, 2017, Journal of Neuroinflammation.

KCa3.1 Inhibition Switches the Astrocyte Phenotype during Astrogliosis Associated with Ischemic Stroke Via Endoplasmic Reticulum Stress and MAPK Signaling Pathways

Hongzhuan Chen, Zhihua Yu, Tianjiao Wei, 2017, Front. Cell. Neurosci..

Ambroxol improves skeletal and hematological manifestations on a child with Gaucher disease

G. Maegawa, Huiwen Zhang, Mengni Yi, 2019, Journal of Human Genetics.

Investigation of GALNS variants and genotype–phenotype correlations in a large cohort of patients with mucopolysaccharidosis type IVA

Xuefan Gu, G. Maegawa, Huiwen Zhang, 2022, Journal of inherited metabolic disease.

KCa3.1 constitutes a pharmacological target for astrogliosis associated with Alzheimer's disease

H. M. Geller, Hongzhuan Chen, Zhihua Yu, 2016, Molecular and Cellular Neuroscience.

Activation of the KCa3.1 channel contributes to traumatic scratch injury-induced reactive astrogliosis through the JNK/c-Jun signaling pathway

Hongzhuan Chen, Zhihua Yu, Fangfang Dou, 2016, Neuroscience Letters.

Potential Disease-Modifying Effects of Lithium Carbonate in Niemann-Pick Disease, Type C1

Dianqing Wu, G. Maegawa, Shiqian Han, 2021, Frontiers in Pharmacology.